^
Association details:
Evidence:
Evidence Level:
Resistant: D – Preclinical
Source:
Title:

PDK4-mediated metabolic reprogramming is involved in rituximab resistance in DLBCL via affecting the expression of MS4A1/CD20

Published date:
07/12/2021
Excerpt:
We found that overexpression of PDK4 in DLBCL cells resulted in cell proliferation and resistance to rituximab in vitro and in vivo.
DOI:
10.1111/cas.15055